Sensars

What the company does

Its public materials describe implantable neurostimulation and research involving people with sensory deficits, including diabetic neuropathy. The technology brings together stimulation hardware, understanding of sensory pathways and clinical development. The company also publishes information about its clinical research. This overview describes a development program, not proof of safety or effectiveness for a particular patient, and does not imply commercial approval.

Areas to understand

• Neuromodulation
• Medical devices
• Clinical development

These themes describe the company’s public focus, not a personalized fit rating. Members bring their own experience, interests and questions to the review process.

Where it fits on Graphora

This company is presented within Healthcare Shares & Red Sky Health. Explore that strategy to see related public overviews, then use your Graphora membership to review available opportunity details.